Bristol-Myers Squibb
BMY
#140
Rank
โ‚ฌ106.72 B
Marketcap
52,45ย โ‚ฌ
Share price
-2.99%
Change (1 day)
7.09%
Change (1 year)

P/E ratio for Bristol-Myers Squibb (BMY)

P/E ratio as of April 2025 (TTM): 14.8

According to Bristol-Myers Squibb's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 14.8262. At the end of 2022 the company had a P/E ratio of 24.1.

P/E ratio history for Bristol-Myers Squibb from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202224.122.82%
202119.7-226.77%
2020-15.5-153.28%
201929.169.66%
201817.2-82.64%
201798.8351.57%
201621.9-69.14%
201570.945.37%
201448.843.19%
201334.121.27%
201228.174.6%
201116.19.38%
201014.7211.7%
20094.72-46.82%
20088.87-63.53%
200724.3-26.05%
200632.9117.62%
200515.1-27.42%
200420.817.26%
200317.8-17.89%
200221.6-55.46%
200148.6

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
13.2-10.92%๐Ÿ‡บ๐Ÿ‡ธ USA
47.5 220.34%๐Ÿ‡บ๐Ÿ‡ธ USA
147 892.13%๐Ÿ‡บ๐Ÿ‡ธ USA
30.2 103.57%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
17.2 16.18%๐Ÿ‡ซ๐Ÿ‡ท France
37.5 153.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
11.4-23.29%๐Ÿ‡บ๐Ÿ‡ธ USA
55.2 272.26%๐Ÿ‡บ๐Ÿ‡ธ USA
21.9 47.47%๐Ÿ‡บ๐Ÿ‡ธ USA
7.11-52.07%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.